|
Updated fields: b4, b6, b7, d10, d9, g3, g6, g7, h2, h3, h4, h6 (medical device problem code, component codes, type of investigation, investigation findings and investigation conclusions), h11.Corrected fields: d4 serial (revert this field to blank, as it was inadvertently submitted initially) and d8 (revert this field to blank, as it was inadvertently submitted initially).The iab was returned with the membrane completely unfolded and blood on the exterior of the catheter.The one-way valve was also returned.The sheath was not returned for evaluation.The one way valve was vacuum tested and it held vacuum.A laboratory insertion test was unable to be performed due to the membrane being unfurled.An underwater leak test of the balloon, catheter, y fitting and extracorporeal tubing was performed and no leaks were detected.A leak may impact the ability to maintain vacuum.Difficult or unable to draw vacuum on iab was unable to be confirmed.Additionally we are unable to confirm the reported difficulty during insertion because of the returned condition of the catheter and we are unable to mimic the clinical setting.Per ifu the one way valve must be aspirated to 30cc while leaving the one way valve in place attached to the extracorporeal tubing leur to ensure vacuum is maintained throughout insertion.The failure mode is addressed in the risk file and is operating within its risk profile.The ifu addresses the reported failure.The investigation does not indicate that the device was inadvertently released as non conforming or an adulterated product or was a counterfeit.The complaint history review did not identify an adverse trend.Based on the rational provided above, no escalation to the capa process is required.
|